Publications Sep 18, 2017 President Trump Blocks Sale of Lattice Semiconductor to Private Equity Fund with Ties to Chinese State-Owned Enterprises, Underscoring Uniquely Difficult Environment for Obtaining CFIUS Approval of Semiconductor Transactions Involving Chinese Investors Sep 18, 2017 First Circuit: Affirms Dismissal of a Securities Fraud Action Challenging Optimistic Statements, “Replete with Caveats,” Concerning FDA Developments Sep 18, 2017 Second Circuit: Supreme Court’s Decision in Salman Abrogated Newman’s “Meaningfully Close Personal Relationship” Test for Tipping Liability Sep 18, 2017 Third Circuit: Describing a Risk as Hypothetical Is Not Misleading Unless That Specific Risk Has Already Materialized Sep 18, 2017 Ninth Circuit: Expressing a Favorable Opinion Concerning FDA Clearance May Be Misleading If the Speaker Does Not Disclose Relevant Adverse FDA Developments Sep 18, 2017 S.D.N.Y.: (1) Courts Must Consider Information in the Public Domain When Assessing the Adequacy of a Company’s Disclosures, and (2) Allegedly Misleading Statements Must Be Viewed in Context Sep 18, 2017 C.D. Cal.: (1) Plaintiffs Must Allege “Concrete” Details to Plead Scienter Under the “Absurd to Suggest” Exception to the Core Operations Theory, and (2) Market Knowledge of the Alleged Fraudulent Practice Is a Prerequisite for Loss Causation Sep 18, 2017 Delaware Chancery Court: (1) MFW’s Framework Governs One-Sided Controller Transactions Involving Disparate Consideration, and (2) MFW’s Procedural Protections Must Be in Place Before the Controller Negotiates for Additional Consideration